PTH and arterial hypertension;Parathormon a nadciśnienie tȩtnicze

Nadcisnienie Tetnicze

Volumn 12, Issue 4, 2008, Pages 253-260

  Bozek, Anna ^a   Pajda, Magdalena ^a   Chudek, Jerzy ^a,b   Wiȩcek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Katedra i Klinika Nefrologii   (Poland)

Author keywords

Arterial hypertension; Parathormon; Parathyreoidectomy; Primary hyperparathyroidism

Indexed keywords

PARATHYROID HORMONE; SODIUM;

ANTIHYPERTENSIVE THERAPY; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; PREVALENCE; REVIEW; SODIUM URINE LEVEL; VASODILATATION;

EID: 54349099788     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Morfis L., Smerdely P., Howes L.G. Relationship between serum parathyroid hormone levels in the elderly and 24 h ambulatory blood pressures. J. Hypertens. 1997; 15: 1271-1276.
2. St John A., Dick I., Hoad K. i wsp. Relationship between calcitrophic hormones and blood pressure in elderly subjects. Eur. J. Endocrinol. 1994; 130: 446-450.
3. Young E.W., McCarron D.A., Morris C.D. Calcium regulating hormones in essential hypertension. Importance of gender. Am. J. Hypertens. 1990; 3; 161-166.
4. McCarron D.A., Pingree P.A., Rubin R.J. i wsp. Enhanced paradiyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 1980; 2: 162-168.
5. Strazzullo P., Nunziata V., Cirillo M. i wsp. Abnormalities of calcium metabolism in essential hypertension. Clin. Sci. 1983; 65: 137-141.
6. Grobbee D.E., Hackeng W.H., Birkenhager J.C. i wsp. Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br. Med. J. 1988; 296: 814-816.
7. Nakamura T., Ichikawa S., Sakamaki T. i wsp. Effect of saline infusion on urinary calcium excretion in essential hypertension. Am. J. Hypertens. 1991; 4: 113-118.
8. Papagalanis N.D., Skopelitis P., Kourti A. i wsp. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension. Nephron 1991; 59: 226-231.
9. Nikkila M.T., Saaristo J.J., Koivula T.A. Clinical and biochemical features in primary hyperparathyroidism. Surgery 1989; 105: 148-153.
10. Rapado A. Arterial hypertension and primary hyperparadiyroidism. Incidence and follow-up after parathyroidectomy. Am. J. Nephrol. 1986; 6: 49-50.
11. Broulik P.D., Horky K., Pacovsky V. Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy. Exp. Clin. Endocrinol. 1985; 86: 346-352.
12. Maheswaran R., Beevers D.G. Clinical correlates in parathyroid hypertension. J. Hypertens. Suppl. 1989; 7: 190-191.
13. Sancho J.J., Rouco J., Riera-Vidal R. i wsp. Long-term effects of parathyroidectomy for primary hyperparathyroidism on arterial hypertension. World J. Surg. 1992; 16: 732-735.
14. Lafferty F.W. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch. Intern. Med. 1981; 141: 1761-1766.
15. Hedback G., Oden A. Death risk factor analysis in primary hyperparathyroidism. Eur. J. Clin. Invest. 1998; 28: 1011-1018.
16. Hellstrom J., Birke G., Edvall C.A. Hypertension in hyperparathyroidism. Br. J. Urol. 1958; 30: 13-24.
17. George J.M., Rabson A.S., Ketcham A. i wsp. Calcareous renal disease and hyperparathyroidism. Q. J. Med. 1965; 34: 291-301.
18. Jones D.B., Jones J.H., Lloyd H.J. i wsp. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism. Postgrad. Med. J. 1983; 59: 350-353.
19. Maheswaran R., Beevers D.G. Clinical correlates in parathyroid hypertension. J. Hypertens. Suppl. 1989; 7: 190-191.
20. Nichols G.A., Metz M.A., Cline W.H. Jr. Endothelium independent linkage of parathyroid hormonereceptors of rat vascular tissue with increased adenosine 3′5′-monophosphate and relaxation of vascular smooth muscle. Endocrinology 1986; 19: 349-356.
21. Jiang B., Morimoto S., Yang J. i wsp. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J. Cardiovasc. Pharmacol. 1998; 31: 142-144.
22. Hanson A.S., Linas S.L. Parathyroid hormone/adenylate cyclase coupling in vascular smooth muscle cells. Hypertension 1994; 23: 468-475.
23. Schluter K.D., Weber M., Piper H.M. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem. J. 1995; 310: 439-444.
24. Shimoyama M., Ogino K., Furuse Y. i wsp. Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart. J. Cardiovasc. Pharmacol. 2001; 38: 491-499.
25. Urena P., Kong X.F., Abou-Samra A.B. i wsp. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 1993; 133: 617-623.
26. Wiȩcek A., Kuczera M., Ganten U. i wsp. Influence of parathyroidectomy on blood pressure and vascular reactivity in spontaneously hypertensive rats. Clin. Exp. Hypertens. 1989; 11: 1515-1533.
27. Schleiffer R., Pernot F., Jones R. Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats. Horm. Metab. Res. 1995; 27: 16-18.
28. Schleiffer R., Xue H., McCarron D.A. i wsp. Effect of chronic and subacute parathyroidectomy on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. J. Hypertens. 1993; 11: 709-716.
29. Kosch M., Hausberg M., Vormbrock K. i wsp. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res. 2000; 47: 813-818.
30. Kosch M., Hausberg M., Barenbrock M., i wsp. Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy. Clin. Nephrol. 2001; 55: 303-308.
31. Jespersen B., Randlov A., Abrahamsen J. i wsp. Effects of PTH (1-34) on blood pressure, renal function, and hormones in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure. Am. J. Hypertens. 1997; 10: 1356-1367.
32. Olgaard K., Lewin E., Bro S. i wsp. Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone. Miner. Electrolyte Metab. 1994; 20: 309-314.
33. Isales C.M., Barrett P.Q., Brines M. i wsp. Parathyroid hormone modulates angiotensin II-induced aldosterone secretion from the adrenal glomerulosa cell. Endocrinology 1991; 129: 489-495.
34. Jiang B., Morimoto S., Fukuo K. i wsp. Role of parathyroid hormone-related protein in the proliferation of vascular smooth muscle cells. Miner. Electrolyte Metab. 1995; 21: 157-160.
35. Nyby M.D., Hino T., Berger M.E. i wsp. Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein. Endocrinology 1995; 136: 2497-2504.
36. Chadwick D.R., Harrison B.J., Chan P., Chong L. i wsp. Vasoactive and proliferative effects of parathyroid hormone and parathyroid hormone-related peptide on human vascular smooth muscle. Br. J. Surg. 2000; 87: 1529-1533.
37. Jorde R., Bonaa K.H., Sundsfjord J. Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromso study. Eur. J. Endocrinol. 1999; 141: 350-357.
38. Young E.W., Morris C.D., McCarron D.A.Y. Urinary calcium excretion in essential hypertension. J. Lab. Clin. Med. 1992; 120: 624-632.
39. Strazzullo P., Galletti F., Cirillo M. i wsp. Altered extracellular calcium homoeostasis in essential hypertension: a consequence of abnormal cell calcium handling. Clin. Sci. (Lond.) 1986; 71: 239-244.
40. Young E.W., Morris C.D., Holcomb S. i wsp. Regulation of parathyroid hormone and vitamin D in essential hypertension. Am. J. Hypertens. 1995; 8: 957-964.
41. Merke J., Lucas P.A., Szabo A. i wsp. Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. Hypertension 1989; 13: 233-242.
42. Rybczyńska A., Boblewski K., Lehmann A. i wsp. Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. Am. J. Hypertens. 2005; 18: 364-371.
43. Peacock M. Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J. Bone Miner. Res. 2002; 17: 87-94.
44. Yamashita H., Noguchi S., Uchino S. i wsp. Influence of renal function on clinico-pathological features of primary hyperparathyroidism. Eur. J. Endocrinol. 2003; 148: 597-602.
45. Evenepoel P., Claes K., Kuypers D. i wsp. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol. Dial. Transplant. 2005; 20: 1714-1720.
46. Rostaing L., Moreau-Gaudry X., Baron E. i wsp. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin. Nephrol. 1997; 47: 248-255.
47. Pajda M., Matug A., Widlak M. i wsp. Influence of parathyroidectomy on blood pressure and function of the transplanted kidney in patients with tertiary hyperparathyroidism. Ann. Transplant. 2006; 11: 11-15.
48. Piovesan A., Molineri N., Casasso F. i wsp. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. 1999; 50: 321-328.
49. Roberts W.C., Waller B.F. Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am. J. Med. 1981; 71: 371-384.
50. Herrmann G., Hehrmann R., Scholz H.C. Parathyroid hormone in coronary artery disease-results of a prospective study. J. Endocrinol. Invest. 1986; 9: 265-271.
51. Andersson P., Rydberg E., Willenheimer R. Primary hyperparathyroidism and heart disease - a review. Eur. Heart J. 2004; 25: 1776-1787.
52. Clemens T.L., Broadus A.E. Physiologic actions of PTH and PTHrp. New York, Academic 2001; 261-273.
53. Garcia de la Torre N., Wass J.A., Turner H.E. Parathyroid adenomas and cardiovascular risk. Endocr. Relat. Cancer 2003; 10: 309-322.
54. Smith J.C., Page M.D., John R. i wsp. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2000; 85: 3513-3514.
55. Weber T., Auer J., O'Rourke M.F. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-189.
56. Rubin M.R., Maurer M.S., McMahon D.J. i wsp. Arterial stiffness in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2005; 90: 3326-3330.
57. Dominiczak A.F., Lyall F., Morton J.J. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin. Sci. (Lond.) 1990; 78: 127-132.
58. Stefenelli T., Abela C., Frank H. i wsp. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J. Clin. Endocrinol. Metab. 1997; 82: 106-112.
59. Schluter K.D., Piper H.M. Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am. J. Physiol. 1992; 263: 1739-1746.
60. Ogino K., Burkhoff D., Bilezikian J.P. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 1995; 136: 3024-3030.
61. Hara M., Liu Y.M., Zhen L. i wsp. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation 1997; 96: 3704-3709.
62. Wang R., Wu L., Karpinski E. i wsp. The changes in contractile status of single vascular smooth muscle cells and ventricular cells induced by bPTH-(1-34). Life Sci. 1993; 52: 793-801.
63. Lewanczuk R.Z., Benishin C.G., Shan J. i wsp. Clinical aspects of parathyroid hypertensive factor. J. Cardiovasc. Pharmacol. 1994; 23: 23-26.
64. Lewanczuk R.Z., Resnick L.M., Ho M.S. i wsp. Clinical aspects of parathyroid hypertensive factor. J. Hypertens. Suppl. 1994; 12: 11-16.